Henry Schein | HSIC - Cost Of Sales

Stock Price
79.72
Daily Change
2.72 3.53%
Monthly
2.02%
Yearly
0.91%
Q1 Forecast
73.16

Henry Schein reported $2.38B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Agilent USD 871M 28M Sep/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bruker USD 481.1M 41.6M Sep/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Cigna USD 63.37B 1.93B Sep/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
CVS Health USD 89.07B 3.74B Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 463M 17M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Henry Schein USD 2.38B 93M Sep/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.54B 11M Sep/2025
McKesson USD 102.47B 2.86B Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Owens Minor USD 2.11B 10.27M Mar/2025
Quest Diagnostics USD 1.91B 49M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Stryker USD 2.69B 373M Dec/2025
Tenet Healthcare USD 3.14B 43M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Universal Health Services USD 2.49B 52.74M Sep/2025
Waters USD 327.81M 5.5M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025
Zoetis USD 683M 3M Sep/2025